Octavian C. Ioachimescu, MD; Saiprakash B. Venkateshiah, MD; Mani S. Kavuru, MD; Kevin McCarthy, RCPT; and James K.
|
|
- Alban West
- 6 years ago
- Views:
Transcription
1 Estimating FVC From FEV 2 and FEV 3 * Assessment of a Surrogate Spirometric Parameter Octavian C. Ioachimescu, MD; Saiprakash B. Venkateshiah, MD; Mani S. Kavuru, MD; Kevin McCarthy, RCPT; and James K. Stoller, MD, MS Background: In the context that accurate measurement of FVC is important in diagnosing airflow obstruction and in assessing restriction, strategies to achieve reliable and accurate FVC measurement have drawn much attention. Objectives: Because the rate of achieving end-of-test criteria during spirometry has been shown to be low, with resultant underrecording of the FVC, the current study proposes a regression equation for estimating FVC from measured values of the forced expiratory volume in 2 s (FEV 2 ) and forced expiratory volume in 3 s (FEV 3 ). Methods: The predictive equation for the estimated FVC from volume measurements within the first 3sofexhalation (estimated FVC 3 ) was generated based on 330 consecutive acceptable spirograms performed in the Cleveland Clinic Foundation Pulmonary Function Laboratory. The equation was applied to an independent validation set comprised of spirometry measurements on 370 different consecutive patients. Results: In the validation spirometry sample, in which the prevalence of obstruction was 34% (based on values of the measured FEV 1 /FVC compared to National Health and Nutrition Examination Survey III values), the sensitivity, specificity, and positive and negative predictive values of FEV 1 /estimated FVC 3 for obstruction were 93.8%, 89.1%, 81.2%, and 96.9%, respectively. The misclassification rate was 9.2%. In the same cohort, the mean difference ( SD) between estimated FVC 3 and measured FVC was ml. Conclusions: Given that FVC is frequently underrecorded, with resultant overestimation of FEV 1 /FVC and underdiagnosis of airflow obstruction, we believe that estimating FVC from FEV 2 and FEV 3 can offer practical diagnostic advantages. (CHEST 2005; 128: ) Key words: airflow obstruction; forced expiratory volume in 3 s; FVC; spirometry Abbreviations: CI confidence interval; estimated FVC 3 estimated FVC from volume measurements within the first3sofexhalation; FET forced expiratory time; FEV 2 forced expiratory volume in 2 s; FEV 3 forced expiratory volume in 3 s; FEV 6 forced expiratory volume in 6 s; LLN lower limit of normal; NHANES National Health and Nutrition Examination Survey; NPV negative predictive value; PPV positive predictive value; RMSE residual mean square error In the context that spirometry is essential in assessing respiratory disorders, FVC is an important measurement to diagnose the presence of obstructive lung disease and to evaluate restrictive disease. At the same time, the accurate measurement of FVC poses challenges to ensure that end-of-test criteria *From the Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, OH. Drs. Ioachimescu and Venkateshiah contributed equally to this article. Manuscript received November 25, 2004; revision accepted February 10, Reproduction of this article is prohibited without written permission from the American College of Chest Physicians ( org/misc/reprints.shtml). Correspondence to: Octavian C. Ioachimescu, MD, Department of Pulmonary, Allergy, and Critical Care Medicine, The Cleveland Clinic Foundation, 9500 Euclid Ave A90, Cleveland, OH 44195; oioac@yahoo.com are met in order to avoid underestimation of FVC, which occurs commonly, as shown by Eaton et al, 1 who demonstrated that among 2,928 expiratory efforts performed in primary care practices, only 28% satisfied an expiratory time 6 s and that 47% were 4 s in duration. Because underestimating FVC can cause the FEV 1 /FVC ratio to be overestimated with resultant underrecognition of airflow obstruction, much attention has been given to assessing spirometric measures that can serve as accurate surrogates for FVC, eg, the forced expiratory volume in 6 s (FEV 6 ). 2 Extending available analyses of FEV 6, 2,3 the current research addresses a strategy for estimating FVC using expiratory efforts of shorter duration, ie, after 3 s. Specifically, the current research addresses the following two questions using two separate cohorts, the developmental and validation 1274 Clinical Investigations
2 groups: how well does the forced expiratory volume in 3 s (FEV 3 ) predict the measured FVC, and what is the diagnostic performance of the FEV 1 /FVC ratio using FVC estimates from the FEV 3 in detecting airflow obstruction? Some of the results of this research have been previously reported in abstract form. 4 Materials and Methods This study examines the diagnostic performance of estimated FVC from volume measurements within the first 3 s of exhalation (estimated FVC 3 ). To develop the prediction equations for estimated FVC 3, data from serial spirometry tests performed on 400 patients tested in the Cleveland Clinic Foundation Pulmonary Function Laboratory between June 6, 2000, and June 19, 2000, were analyzed. The prediction equations and the diagnostic performance of FEV 1 /estimated FVC 3 in detecting airflow obstruction were then assessed in a separate, independent sample of 377 spirograms performed in the same laboratory between June 3, 2002, and June 14, Criteria for acceptability and reproducibility of spirometry measurements were those specified by the American Thoracic Society. 5 As previously described, 6 spirometry (Jaeger Master Lab Pro; Erich Jaeger GmbH; Wurzburg, Germany) was performed using a modified expiratory technique in which the subject was asked to perform a maximally forceful exhalation for 3 s, and thereafter to continue to exhale slowly (ie, in a relaxed fashion) as long as possible. Height was measured to the nearest centimeter without shoes, and weight was recorded to the nearest kilogram. Each spirometer was calibrated daily with a 3-L syringe. Forced expiratory volume in 2 s (FEV 2 ), FEV 3, and all other standard spirometric indexes were measured using software (Erich Jaeger GmbH). To determine the regression equation for estimated FVC 3, several independent variables were examined. Candidate variables were FEV 1, FEV 1 percentage of predicted, FEV 2, FEV 3, and the difference between the volume exhaled in 3 s and 2 s (FEV 3 FEV 2 ). The difference between estimated FVC 3 obtained from the regression equation and measured FVC was calculated. Also, the FEV 1 /estimated FVC 3 ratio was compared to the lower limit of the FEV 1 /FVC ratio from the National Health and Nutrition Examination Survey III (NHANES III) reference set. 3 In keeping with current guidelines, 7 FEV 1 /FVC was used to diagnose airflow obstruction, which was deemed to be present if FEV 1 /FVC ratio fell below the lower limit of normal (LLN) in the NHANES III reference set. 3 Based on Global Initiative for Chronic Obstructive Lung Disease staging criteria 7 (in which the diagnosis of airflow obstruction is based on values of FEV 1 /FVC 0.70), the severity of airflow obstruction was graded by FEV 1 into three categories: mild ( 80% predicted), moderate (30 to 80% predicted), and severe ( 30% predicted). Statistical analysis was performed using statistical software (SigmaStat 2.03; SPSS; Chicago, IL; and JMP 5.01; SAS Institute; Cary, NC). Main statistical tests performed were 2 analysis and Kruskal-Wallis analysis of variance. To assess agreement between FVC and estimated FVC 3, a discriminative analysis was performed using the Bland and Altman method. 8 Values of p 0.05 were considered statistically significant. Results For developing the regression equation, 400 spirometry studies were collected, of which 70 records (17.5%) were excluded (Table 1). Reasons for excluding spirograms included the following: exhalation time 6s(n 55), no mention of race (n 9), females 18 years old (n 3), and males 20 years old (n 3). Of the 330 subjects whose spirograms were used, 284 were white and 46 were black. One hundred seventy-six were male, and 154 were female. One hundred forty patients (42.4%) had obstruction (mild [n 14], moderate [n 90], and severe [n 36]). Eighty-two patients (24.8%) had restriction, none (0%) had both obstruction and restriction, and 108 patients (32.7%) were normal. Mean expiratory time in these 330 spirograms was 10.3 s (95% confidence interval [CI], 9.9 to 10.6 s; SD, 3.2 s). Using these 330 spirometry measurements in the developmental data set, after considering different models, the best-fit model was a linear regression equation for predicting FVC: estimated FVC FEV FEV 3 FEV 2 liters where R , RMSE (residual mean square error) 0.25, p (Fig 1). The mean difference between estimated FVC 3 and FVC was 0.6 ml (95% CI, 16.1 to 16.0 ml; SD, 148 ml). Values of estimated FVC 3 were within 200 ml of the measured FVC in 201 of 330 tests (60%). Table 2 presents demographic and spirometric characteristics of the 330 subjects whose spirometry measurements comprise the developmental data set, stratified by those whose FVC and estimated FVC 3 were within 200 ml, those whose estimated FVC 3 exceeded the measured FVC by 200 ml, and those whose measured FVC exceeded the estimated FVC 3 by 200 ml. This last group had longer forced expiratory time (FETs) and lower FEV 1 /FVC compared to the other two groups. Table 3 presents the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of FEV 1 /estimated FVC 3 in detecting Table 1 Reasons for Excluding Spirograms From the Developmental Data Set Reason for Exclusion No. Short exhalation time (FET 6 s) and no expiratory 32 plateau Abrupt termination of expiration (glottic closure) 7 Cough in first second or hesitant start 6 No race specified (unable to calculate predicted value) 9 Pediatric patient 6 Short exhalation time (FET 6 s) but valid plateau 10 (analyzed separately) Total 70 CHEST / 128 / 3/ SEPTEMBER,
3 Figure 1. Comparison of actual FVC with estimated FVC 3 in the developmental data set (n 330). airflow obstruction, as defined by measured values of FEV 1 /FVC according to NHANES III criteria. The PPV of estimated FVC 3 for identifying obstruction was 82.7%, and the NPV for excluding obstruction was 96.4%. The likelihood ratio for detecting obstruction was 6.5. The misclassification rate was 10.3%. To assess estimated FVC 3 under conditions of short expiratory times, we evaluated the 10 spirograms that had a short exhalation (FET 6 s) but a valid expiratory plateau. In 60% (6 of 10 spirograms), estimated FVC 3 value was within 200 ml of the actual FVC. None of these 10 patients had obstruction. In the context of excluding from both development and validation groups the tests with short expiratory times ( 6 s), we do not know if the above prediction equation applies to spirograms with short exhalation, even when a visually apparent expiratory plateau is reached earlier than 6 s. To validate the diagnostic utility of estimated FVC 3, the values derived from the regression equation in the developmental set were compared to actual FVC values in a separate validation cohort of 377 subjects, who performed technically acceptable spirograms obtained in the Cleveland Clinic Foundation Pulmonary Function Laboratory between June 3, 2002, and June 14, As shown in Figure 2, the mean difference between estimated FVC 3 and actual FVC was 24.7 (95% CI, 0.7 to 48.8 ml; SD, 237 ml). The estimated FVC 3 explained 94.7% of the variance in measured FVC (p 0.001). Mean expiratory time in these 377 spirograms was 10.6 s (95% CI, 10.3 to 11.0 s; range, 6.0 to 18.6 s; median, 10.1 s). In our pulmonary function laboratory, which uses the modified exhalation technique almost exclusively, the mean expiratory time calculated on 4,413 patients tested during the same period 2 years before the study (2000) was 11.8 s. For patients with obstruction (n 1,826, 41% of the spirograms), the mean expiratory time was 13.5 s. The expiratory time distribution by FEV 1 /FVC ratio was as follows: 11.8 s (70 to 80%), 13.5 s (30 to 69%), and 15 s ( 29%). In evaluating the diagnostic performance of the estimated FVC 3 /FVC for detecting obstruction, PPV and NPV were 81% and 96%, respectively (Table 4), quite similar to the values in the developmental cohort (Table 3). Bland and Altman analysis of data in the validation group (Fig 3), plotting the difference between estimated FVC 3 and FVC against their average, showed a 95% CI of the mean of (0.7 to 48.8 ml); the SD of the difference was 237 ml. Finally, the likelihood ratio for diagnosing obstruction using the FEV 1 /estimated FVC 3 in the validation cohort was 8.6, and the misclassification rate was 9.2% (Table 4) Clinical Investigations
4 Table 2 Demographic and Spirometric Characteristics of the Developmental Cohort Stratified by Degree of Agreement Between the Actual FVC and the Estimated FVC 3 * Characteristics FVC and Estimated FVC 3 Within 0.2 L Estimated FVC 3 Greater Than FVC by 0.2 L Estimated FVC 3 Less Than FVC by 0.2 L All p 0.05 (Groups) Patients, No Female/male gender 96/105 48/25 10/46 154/176 1 vs 2, 2 vs 3, 1 vs 3 Black/white race 28/173 12/61 4/52 46/284 NS Age, yr NS Height, cm vs2,2vs3,1vs3 Weight, kg NS BMI vs3 FVC, L vs 2, 2 vs 3 FEV 1,L vs2,1vs3 FEV 1 /FVC, % vs 3, 2 vs 3 FET, s vs3,2vs3 FEV 2,L vs 2, 1 vs 3 FEV 3,L vs 2, 1 vs 3 FVC, % vs 2, 2 vs 3 FEV 1,% vs 2, 1 vs 3 FEV 3 FEV 2,L vs 2 Estimated FVC 3,L vs 2 FEV 1 /estimated FVC 3, (%) vs 2, 1 vs 3 FVC estimated FVC 3,L vs 2, 2 vs 3, 1 vs 3 *Data are presented as mean SD or No. NS not significant. To further assess the estimated FVC 3, we evaluated the correlations with actual FVC and detection of obstruction in the subset of validation set spirograms that achieved (34%) vs those that did not achieve an expiratory plateau (66%). The strength of the correlations, the variances, and the statistical significance of the predictive equations were similar in both subsets (ie, in those achieving an expiratory plateau, R , RMSE 0.217, p ; and in those not achieving an expiratory plateau, R , RMSE 0.238, p ). The sensitivity, specificity, PPV, and NPV were similar in the group of spirograms with expiratory plateau and in the group without a valid expiratory plateau, ie, 92%, 84%, 60%, 97%, and 94%, 91%, 88%, 95%, respectively. Also, dichotomizing the spirograms in the validation set by those in which estimated FVC 3 underestimated measured FVC vs those in which the estimated FVC 3 overestimated the measured FVC group, we observed that the predictive equation produced the following sensitivities, specificities, PPVs, and NPVs: 100%, 92%, 88%, 100% and 68%, 100%, 100%, 81%, respectively. The statistic degree of agreement in detecting obstruction varied between 0.79 and 0.89 among different subgroups (plateau vs nonplateau, underestimated vs overestimated FVC). Discussion The main findings of this study are as follows: (1) FEV 3 can be used to estimate FVC with reasonable accuracy. Although this surrogate parameter confers benefits for interpreting spirometry results when spirometric end-of-test criteria are not satisfied, Table 3 Comparison of FEV 1 /Estimated FVC 3 With FEV 1 /FVC in Patients With or Without Airflow Obstruction in the Developmental Cohort* FEV 1 /FVC Variables Obstruction (Value Less Than LLN) No Obstruction (Value Greater Than LLN) Total FEV 1 /estimated FVC 3 indicates obstruction FEV 1 /estimated FVC 3 indicates no obstruction Total *Sensitivity 95.7% (95% CI, 91.4 to 98.2%); specificity 85.3% (95% CI, 82.1 to 87.1%); PPV 82.7% (95% CI, 79.0 to 84.8%); NPV 96.4% (95% CI, 92.9 to 98.5%); misclassification rate 34/330 (28 6/330) 10.3%. LLN in NHANES III data set. CHEST / 128 / 3/ SEPTEMBER,
5 Figure 2. Comparison of actual FVC with estimated FVC 3 in the validation data set (n 377). estimates of the true FVC are imperfect and use of the FEV 1 /estimated FVC 3 does not eliminate the risk of misclassifying the presence of obstruction. (2) Compared with the actual ratio of FEV 1 /FVC, the ratio of FEV 1 /estimated FVC 3 demonstrated reasonably good, albeit imperfect, diagnostic performance in detecting airflow obstruction and excellent performance in excluding obstruction. For example, in the validation data set, the PPV of FEV 1 /estimated FVC 3 for detecting obstruction was 81.2% and the NPV was 96.9%. (3) Although use of a surrogate parameter has appeal, its imperfect diagnostic performance should not detract from efforts to optimize performance of spirometry, eg, through technician training and active quality control of testing. Based on the acceptable diagnostic performance of estimated FVC 3 and the fact that many patients do not achieve even 6 s of exhalation, our findings suggest that the estimated FVC 3 derived from measured values of FEV 2 and FEV 3 can be a useful spirometric parameter. That failure to achieve spirometric end-of-test criteria or even 6 s of exhalation is common has been shown by Eaton et al. 1 Recognizing that equipment features may have contributed to end-of-test failures in this study, among 2,928 expiratory measures only 28% achieved an expiratory time of 6 s. The remaining 72% of the blows (n 2,103) lasted 6s, including 47% (n 1,380) that were 4 s in duration. Visual inspection of the spirograms showed that Table 4 Comparison of FEV 1 /Estimated FVC 3 With FEV 1 /FVC in Patients With or Without Airflow Obstruction in the Validation Cohort* FEV 1 /FVC Variables Obstruction (Value Less Than LLN) No Obstruction (Value Greater Than LLN) Total FEV 1 /estimated FVC 3 indicates obstruction FEV 1 /estimated FVC 3 indicates no obstruction Total *Sensitivity 93.8% (95% CI, 91.4 to98.2%); specificity 89.1% (95% CI, 82.1 to 87.1%); PPV 81.2% (95% CI, 79.0 to 84.8%); NPV 96.9% (95% CI, 92.9 to 98.5%); misclassification rate 35/377 (27 8/377) 9.2%. LLN in NHANES III data set Clinical Investigations
6 Figure 3. Bland and Altman plot of estimated FVC 3 and actual FVC. The middle line represents the mean, while the other lines represent 1, 2, 1, and 2 SDs of the differences (R , p ). The analysis, which is a conventional method for evaluating new measurement techniques, plots the dispersion of individual differences between the measurements against their means. Mean difference in liters, ; SE, (upper 95%, ; lower 95%, ); SD, (upper 95%, 0.255; lower 95%, 0.221); N 377; R % of the curves that failed to achieve 6sof duration had expiratory plateaus, suggesting that most of the test failures were due to early termination of effort. As shown by Townsend et al, 9 early termination of expiration can confound the interpretation of the spirogram. Specifically, short durations of expiration cause undermeasurement of FVC, thereby overestimating values of FEV 1 /FVC. The diagnostic impact of overestimating FEV 1 /FVC by underrecording FVC was such that after 3 s of expiration, 60 of the 80 subjects (75%) were classified with FEV 1 /FVC ratios 80%, and 2 subjects (3%) had FEV 1 /FVC ratios 69%. The distribution of FEV 1 /FVC values was a distortion of the FEV 1 /FVC distribution that was based on complete expirations, in which only 18 of the subjects (23%) had FEV 1 /FVC ratios 80% and 21 subjects (26%) had FEV 1 /FVC ratios 69%. Therefore, the proportions of individuals with normal and abnormal FEV 1 /FVC values varied dramatically with the length of expiration recorded, with fewer abnormal FEV 1 /FVC values produced after a short-recorded expiration. Most of the subjects with low FEV 1 /FVC were misclassified after only 3sof expiration, and many were misclassified even after 6 s of expiration. In another study, Graham et al 10 showed a risk of reaching spurious spirometric conclusions based on underrecorded expirations in finding that FVC in Vermont granite workers appeared to increase by a mean of 0.54 L over a 5-year period. Evaluation of the spirograms showed that these observed increases in FVC were probably caused by comparing underrecorded baseline FVC values (ie, measured after 2.5 to 3 s of expiration) to FVC values based on longer expirations (exceeding 6 s of expiratory effort) recorded on follow-up tests performed 5 years later. This observation underscores the importance of assessing the FET in evaluating and comparing values of FVC. Based on these pitfalls of underrecorded FVC values, the National Lung Health Education Program and others 2,11 have recommended use of FEV 6 as a surrogate for FVC. In the context that even 6 s of exhalation are often not achieved, an approach of estimating FVC based on measures values of FEV 2 and FEV 3 has appeal. At the same time, satisfying end-of-test criteria and ensuring that the value of FVC is reliable would obviate the need for estimating the FVC (as with equation proposed here) or using a surrogate parameter like the FEV 6. In the context that failure to achieve acceptable CHEST / 128 / 3/ SEPTEMBER,
7 spirometry efforts is common, it is imperative that pulmonary function laboratories undertake both careful quality review and technician training. Still, although it is tempting to propose enhanced technician training as a solution to optimize spirometry performance, several studies suggest that training, while useful, does not completely ensure consistent achievement of end-of-test criteria. For example, despite offering a spirometry workshop to technicians at the start of the study by Eaton et al, 1 only 39% of the 923 expiratory efforts achieved expiratory times 6 s. Of the tests performed by technicians who received no formal spirometry workshop training, only 16% of 1,285 expiratory efforts achieved expiratory times of 6s. 1 Others have reported failure to achieve American Thoracic Society criteria for acceptability and reproducibility in 8 to 20% of spirometry test sessions. More extensive training and electronic spirometer feedback as in the Lung Health Study 12 can improve the rate but still failed to completely ensure uniform achievement of full expiratory times. Specifically, 2.1% of test sessions in the Lung Health Study 12 did not meet American Thoracic Society acceptability and reproducibility criteria. Finally, in the National Heart, Lung, and Blood Institute Registry of Individuals With Severe Deficiency of 1 Antitrypsin, 18 in which technicians underwent extensive initial group training, received regular feedback on their technical performance in spirometry, and experienced site visits for biological control testing, the rate of failing to achieve end-oftest criteria was still 69% even though spirometry reproducibility was quite high. 18 Clearly, though extensive training has been shown to improve technical performance in spirometry, it is impractical to propose widespread spirometric training of the sort described in these highly quality-controlled studies, especially in the face of official calls for widespread office-based spirometry (as by the National Lung Health Education Program). 11 In this regard, estimating FVC from values of FEV 2 and FEV 3, which can be achieved more easily than FVC, also has appeal. It bears mention that a tight quality control review process remains a critical component of good spirometry performance, whether using standard parameters or the FVC estimates discussed here. Indeed, only by such ongoing review can attention to all the methodologic requirements of good spirometry (eg, adequate start and end of test, complete inhalation) be optimized. As we imagine extending use of the estimated FVC 3 to more widespread spirometric practice, a favorable feature is that several large manufacturers of spirometers already report both FEV 2 and FEV 3 (eg, Koko Spirometer; Pulmonary Data Services; Louisville, CO; V max Spectra; SensorMedics; Yorba Linda, CA; Erich Jaeger spirometers; Wurzburg, Germany), making calculation of estimated FVC 3 readily possible. Many other manufacturers currently report the FEV 3 and could likely easily add reporting of FEV 2 if warranted by market demands. With these observations in mind, estimated FVC 3 may be preferable to FEV 6, which is not currently available as a readout on many commercial spirometers. Several shortcomings of this study warrant comment. First, the predictive values of FEV 1 /estimated FVC 3 for airflow obstruction expectedly depend on the prevalence of airflow obstruction in the population studied. In the two study cohorts considered here, airflow obstruction was evident in 34 to 42% of the spirograms. Were airflow obstruction more prevalent, the PPV of FEV 1 /estimated FVC 3 would have been higher than the value of 81% observed in the validation set and the NPV would be expected to be lower. Second, because our regression equation was derived from spirograms obtained using the modified technique that is routinely used in our pulmonary function laboratory (in which the patient is instructed to relax and push gently after the first 3sof maximally forced expiration), whether these results will be robust for spirometric data generated with a traditional technique with sustained forced expiration is uncertain. Because our earlier randomized controlled trial of this modified spirometric technique showed that its use allowed more frequent accomplishment of end-of-test criteria and higher values of FVC than were obtained using the traditional technique, 6 validation of the regression equation for spirometric data obtained with this traditional technique will be needed for those laboratories still using that approach. Third, because our results were derived from a population of adults, their application to pediatric populations is unproven. And fourth, the fact that the calculated FVC could be lower than measured FVC, even if an expiratory plateau was achieved, highlights a limitation of the estimation. Our analysis failed to identify any specific demographic features or spirometric parameters that predict underestimation of the measured FVC by estimated FVC 3. In the context that technical errors in performing spirometry are unlikely to underestimate the FVC, we suggest several conditions that should be satisfied in order to optimally use the estimated FVC 3. Specifically, if the value of estimated FVC 3 is lower than the measured FVC, the measured FVC should be used. Similarly, because our validation set contained no spirograms in which the FET was 6s(ie, range of FETs was 6 to 18.6 s), validation of estimated FVC Clinical Investigations
8 in a population where FET is 6 s is needed before use of the predictive equation can be endorsed. In summary, the current report presents a regression equation by which FVC can be estimated from measured values of FEV 2 and FEV 3 and then validates the regression equation in an independent, validation cohort. Of note, our predictive equation applies to spirograms with expiratory time of at least 6 s not achieving an expiratory plateau. In the context that the FVC is frequently underrecorded with resultant overestimation of FEV 1 /FVC ratio and underdiagnosis of airflow obstruction, we believe that estimating FVC from FEV 2 and FEV 3 may offer diagnostic and practical advantages, especially when complete expiration cannot be achieved. We encourage further investigation of this estimation method in order to better assess its generalizability and application to specific patient groups (eg, pediatric populations, and those tested with conventional spirometric techniques). References 1 Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999; 116: Swanney MP, Jensen RL, Crichton DA, et al. FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction. Am J Respir Crit Care Med 2000; 162: Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: Venkateshiah SB, McCarthy K, Kavuru MS, et al. Identifying obstruction using a three-second exhalation by extrapolating the forced vital capacity (FVC). Chest 2003; 124(Suppl):122S 5 American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: Stoller JK, Basheda S, Laskowski D, et al. Trial of standard versus modified expiration to achieve end-of-test spirometry criteria. Am Rev Respir Dis 1993; 148: Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines, global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Workshop report. Bethesda, MD: National Heart, Lung and Blood Institute, National Institute of Health, Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: Townsend MC, Du Chene AG, Fallat RJ. The effects of underrecorded forced expirations on spirometric lung function indexes. Am Rev Respir Dis 1982; 126: Graham WG, O Grady RV, Dubuc B. Pulmonary function loss in Vermont granite workers: a long-term follow-up and critical reappraisal. Am Rev Respir Dis 1981; 123: Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000; 117: Enright PL, Johnson LR, Connett JE, et al. Spirometry in the Lung Health Study: 1. Methods and quality control. Am Rev Respir Dis 1991; 143: Eisen EA, Wegman DH, Louis TA. Effects of selection in a prospective study of forced expiratory volume in Vermont granite workers. Am Rev Respir Dis 1983; 128: Eisen EA, Oliver LC, Christiani DC, et al. Effects of spirometry standards in two occupational cohorts. Am Rev Respir Dis 1985; 132: Kellie SE, Attfield MD, Hankinson JL, et al. Spirometry variability criteria association with respiratory morbidity and mortality in a cohort of coal miners. Am J Epidemiol 1987; 125: Kanner RE, Schenker MB, Munoz A, et al. Spirometry in children: methodology for obtaining optimal results for clinical and epidemiologic studies. Am Rev Respir Dis 1983; 127: Eisen EA, Dockery DW, Speizer FE, et al. The association between health status and the performance of excessively variable spirometry tests in a population-based study in six U.S. cities. Am Rev Respir Dis 1987; 136: Stoller JK, Buist AS, Burrows B, et al. Quality control of spirometry testing in the registry for patients with severe 1 -antitrypsin deficiency: Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest 1997; 111: CHEST / 128 / 3/ SEPTEMBER,
Spirometry is the most frequently performed. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6
Eur Respir J 2006; 27: 378 383 DOI: 10.1183/09031936.06.00036005 CopyrightßERS Journals Ltd 2006 Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/ and J. Vandevoorde*, S. Verbanck
More informationSpirometry Training Courses
Spirometry Training Courses A Position Paper of The Australian and New Zealand Society of Respiratory Science & The Thoracic Society of Australia and New Zealand At the time of the preparation of this
More informationUsing Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern
44 The Open Respiratory Medicine Journal, 2011, 5, 44-50 Using Spirometry to Rule Out Restriction in Patients with Concomitant Low Forced Vital Capacity and Obstructive Pattern Open Access Imran Khalid
More informationOriginal Contributions
Original Contributions Comparison of a New Desktop Spirometer (Spirospec) with a Laboratory Spirometer in a Respiratory Out-Patient Clinic François Swart, Macé M Schuurmans MD, Johannes C Heydenreich,
More informationPREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION
Prediction Equations for Lung Function in Healthy, Non-smoking Malaysian Population PREDICTION EQUATIONS FOR LUNG FUNCTION IN HEALTHY, LIFE TIME NEVER-SMOKING MALAYSIAN POPULATION Justin Gnanou, Brinnell
More informationbehaviour are out of scope of the present review.
explained about the test, a trial may be done before recording the results. The maneuver consists initially of normal tidal breathing. The subject then inhales to maximally fill the lungs. This is followed
More informationUnderstanding the Basics of Spirometry It s not just about yelling blow
Understanding the Basics of Spirometry It s not just about yelling blow Carl D. Mottram, RRT RPFT FAARC Technical Director - Pulmonary Function Labs and Rehabilitation Associate Professor of Medicine -
More informationPulmonary Function Testing
In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this
More informationAssessment of accuracy and applicability of a new electronic peak flow meter and asthma monitor
Eur Respir J 18; 12: 45 42 DOI: 18/1.8.5 Printed in UK - all rights reserved Copyright ERS Journals Ltd 18 European Respiratory Journal ISSN - 1 Assessment of accuracy and applicability of a new electronic
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationPeak Expiratory Flow Is Not a Quality Indicator for Spirometry*
Original Research PULMONARY FUNCTION TESTING Peak Expiratory Flow Is Not a Quality Indicator for Spirometry* Peak Expiratory Flow Variability and FEV 1 Are Poorly Correlated in an Elderly Population Matthew
More informationRelationship Between FEV1& PEF in Patients with Obstructive Airway Diseases
OBSTRUCTIVE THE IRAQI POSTGRADUATE AIRWAY MEDICAL DISEASES JOURNAL Relationship Between FEV1& PEF in Patients with Obstructive Airway Diseases Muhammed.W.AL.Obaidy *, Kassim Mhamed Sultan*,Basil Fawzi
More informationDifference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
ISPUB.COM The Internet Journal of Pulmonary Medicine Volume 4 Number 2 Difference Between The Slow Vital Capacity And Forced Vital Capacity: Predictor Of Hyperinflation In Patients With Airflow Obstruction
More informationSpirometric protocol
Spirometric protocol Spirometry is the most common of the Pulmonary Function Test, that measures lung function, specifically the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled.
More informationThe Relationship Between FEV 1 and Peak Expiratory Flow in Patients With Airways Obstruction Is Poor*
Original Research PULMONARY FUNCTION TESTING The Relationship Between FEV 1 and Peak Expiratory Flow in Patients With Airways Obstruction Is Poor* Ashutosh N. Aggarwal, MD, FCCP; Dheeraj Gupta, MD, FCCP;
More informationS P I R O M E T R Y. Objectives. Objectives 2/5/2019
S P I R O M E T R Y Dewey Hahlbohm, PA-C, AE-C Objectives To understand the uses and importance of spirometry testing To perform spirometry testing including reversibility testing To identify normal and
More informationUNIT TWO: OVERVIEW OF SPIROMETRY. A. Definition of Spirometry
UNIT TWO: OVERVIEW OF SPIROMETRY A. Definition of Spirometry Spirometry is a medical screening test that measures various aspects of breathing and lung function. It is performed by using a spirometer,
More informationPurpose Of This Guide
AOHC Session 5 April 9, Speaker Disclosures Spirometry Testing in Occupational Health Programs Best Practices for Healthcare Professionals Mary C. Townsend, Dr.P.H M.C. Townsend Associates, LLC Adjunct
More informationGetting Spirometry Right It Matters! Performance, Quality Assessment, and Interpretation. Susan Blonshine RRT, RPFT, AE-C, FAARC
Getting Spirometry Right It Matters! Performance, Quality Assessment, and Interpretation Susan Blonshine RRT, RPFT, AE-C, FAARC Objectives Sample Title Recognize acceptable spirometry that meets the start
More informationPulmonary Function Tests. Mohammad Babai M.D Occupational Medicine Specialist
Pulmonary Function Tests Mohammad Babai M.D Occupational Medicine Specialist www.drbabai.com Pulmonary Function Tests Pulmonary Function Tests: Spirometry Peak-Flow metry Bronchoprovocation Tests Body
More informationSPIROMETRY TECHNIQUE. Jim Reid New Zealand
Jim Reid New Zealand The Basics Jim Reid Spirometry measures airflow and lung volumes, and is the preferred lung function test in COPD. By measuring reversibility of obstruction, it is also diagnostic
More informationClinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene
Clinical and radiographic predictors of GOLD-Unclassified smokers in COPDGene Emily S. Wan, John E. Hokanson, James R. Murphy, Elizabeth A. Regan, Barry J. Make, David A. Lynch, James D. Crapo, Edwin K.
More informationOffice Based Spirometry
Osteopathic Family Physician (2014)1, 14-18 Scott Klosterman, DO; Woodson Crenshaw, OMS4 Spartanburg Regional Family Medicine Residency Program; Edward Via College of Osteopathic Medicine - Virginia Campus
More informationPULMONARY FUNCTION TESTING. By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS)
PULMONARY FUNCTION TESTING By: Gh. Pouryaghoub. MD Center for Research on Occupational Diseases (CROD) Tehran University of Medical Sciences (TUMS) PULMONARY FUNCTION TESTS CATEGORIES Spirometry Lung volumes
More informationS P I R O M E T R Y. Objectives. Objectives 3/12/2018
S P I R O M E T R Y Dewey Hahlbohm, PA-C, AE-C Objectives To understand the uses and importance of spirometry testing To perform spirometry testing including reversibility testing To identify normal and
More informationMSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C
MSRC AIR Course Karla Stoermer Grossman, MSA, BSN, RN, AE-C Explain the importance of objective measures in the management of asthma Explain the different types of objective measures used in the management
More informationContent Indica c tion Lung v olumes e & Lung Indica c tions i n c paci c ties
Spirometry Content Indication Indications in occupational medicine Contraindications Confounding factors Complications Type of spirometer Lung volumes & Lung capacities Spirometric values Hygiene &
More informationStability of the EasyOne ultrasonic spirometer for use in general practice
Blackwell Publishing AsiaMelbourne, AustraliaRESRespirology1323-77992006 Blackwell Publishing Asia Pty Ltd2006113306310MiscellaneousCalibration of an ultrasonic spirometerjae Walters et al. Respirology
More informationSPIROMETRY. Marijke Currie (CRFS) Care Medical Ltd Phone: Copyright CARE Medical ltd
SPIROMETRY Marijke Currie (CRFS) Care Medical Ltd Phone: 0800 333 808 Email: sales@caremed.co.nz What is spirometry Spirometry is a physiological test that measures the volume of air an individual can
More informationSupplementary Online Content
Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published
More informationLung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects
Lung Function Basics of Diagnosis of Obstructive, Restrictive and Mixed Defects Use of GOLD and ATS Criteria Connie Paladenech, RRT, RCP, FAARC Benefits and Limitations of Pulmonary Function Testing Benefits
More informationHow to Perform Spirometry
Purpose How to Perform Spirometry This guideline provides recommendations regarding best practice to support high quality spirometry practice for KINNECT Pre-Employment Medicals. Scope This guideline provides
More informationE. Prescott + **, P. Lange* +, J. Vestbo**
Eur Respir J, 1995, 8, 1333 1338 DOI: 10.1183/09031936.95.08081333 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Chronic mucus hypersecretion
More informationBETTER SPIROMETRY. Marijke Currie (CRFS) Care Medical Ltd Phone: Copyright CARE Medical ltd
BETTER SPIROMETRY Marijke Currie (CRFS) Care Medical Ltd Phone: 0800 333 808 Email: sales@caremed.co.nz What is spirometry Spirometry is a physiological test that measures the volume of air an individual
More informationComparison between FEV1/FEV6 and FEV1/FVC as screening of chronic obstructive pulmonary disease
ORIGINAL ARTICLE Comparison between FEV1/FEV6 and FEV1/FVC as screening of chronic obstructive pulmonary disease Ng Seow Ching, MRCP, Mohd Faizul Bin Abu Samah, MRCP, Khaled Mohamed Helmy Abd El-Aziz,
More informationPulmonary Function Testing. Ramez Sunna MD, FCCP
Pulmonary Function Testing Ramez Sunna MD, FCCP Lecture Overview General Introduction Indications and Uses Technical aspects Interpretation Patterns of Abnormalities When to perform a PFT 1. Evaluation
More informationSpirometry: Introduction
Spirometry: Introduction Dr. Badri Paudel 1 2 GMC Spirometry Spirometry is a method of assessing lung function by measuring the volume of air the patient can expel from the lungs after a maximal expiration.
More informationSpirometry Workshop for Primary Care Nurse Practitioners
Spirometry Workshop for Primary Care Nurse Practitioners Catherine Casey S. Jones PhD, RN, AE-C, ANP-C Certified Adult Nurse Practitioner Texas Pulmonary & Critical Care Consultants P.A. and Adjunct Professor
More informationPEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to
More informationSpirometry: FEVER DISEASE DIABETES HOW RELIABLE IS THIS? 9/2/2010 BUT WHAT WE PRACTICE: Spirometers are objective tools
SPIROMETRY PRINCIPLES, PROCEDURE AND QA Spirometry: Dr. Rahul Kodgule CHEST RESEARCH FOUNDATION, PUNE FEVER ISCHAEMIC HEART DISEASE DIABETES BUT WHAT WE PRACTICE: Spirometers are objective tools to diagnose
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Wells JM, Farris RF, Gosdin TA, et al. Pulmonary
More informationWhat do pulmonary function tests tell you?
Pulmonary Function Testing Michael Wert, MD Assistant Professor Clinical Department of Internal Medicine Division of Pulmonary, Critical Care, and Sleep Medicine The Ohio State University Wexner Medical
More informationRespiratory Function Testing Is Safe in Patients With Abdominal Aortic Aneurysms.
Respiratory Function Testing Is Safe in Patients With Abdominal Aortic Aneurysms. Author Zagami, Debbie, Wilson, Jessica, Bodger, Alanna, Sriram, Krishna Published 2014 Journal Title Vascular and Endovascular
More informationBreathing and pulmonary function
EXPERIMENTAL PHYSIOLOGY EXPERIMENT 5 Breathing and pulmonary function Ying-ying Chen, PhD Dept. of Physiology, Zhejiang University School of Medicine bchenyy@zju.edu.cn Breathing Exercise 1: Tests of pulmonary
More informationSpirometry and Flow Volume Measurements
Spirometry and Flow Volume Measurements Standards & Guidelines December 1998 To serve the public and guide the medical profession Revision Dates: December 1998 Approval Date: June 1998 Originating Committee:
More informationEvaluation of efficacy and utility of spirometry data in elderly
International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20185109 Evaluation of efficacy
More informationAirway Obstruction Among Latino Poultry Processing Workers in North Carolina
Airway Obstruction Among Latino Poultry Processing Workers in North Carolina By: Maria C. Mirabelli, Arjun B. Chatterjee, Dana C. Mora, Thomas A. Arcury, Jill N. Blocker, Haiying Chen, Joseph G. Grzywacz,
More information#8 - Respiratory System
Page1 #8 - Objectives: Study the parts of the respiratory system Observe slides of the lung and trachea Equipment: Remember to bring photographic atlas. Figure 1. Structures of the respiratory system.
More information#7 - Respiratory System
#7 - Respiratory System Objectives: Study the parts of the respiratory system Observe slides of the lung and trachea Perform spirometry to measure lung volumes Define and understand the lung volumes and
More information2.0 Scope: This document is to be used by the DCS staff when collecting participants spirometry measurements using the TruFlow Easy-On Spirometer.
Title: Spirometry Version Date: 2017-MAR-21 Document Effective Date: 2017-MAY-15 Number: Data Collection Site (DCS) Version: 2.3 Number of Pages: SOP_DCS_0012 6 1.0 Purpose: The purpose of this document
More informationPeak expiratory flow and the resistance of the mini-wright peak flow meter
Eur Respir J, 1996, 9, 828 833 DOI: 10.1183/09031936.96.090828 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1996 European Respiratory Journal ISSN 0903-1936 TECHNICAL NOTE Peak expiratory
More informationImpact of the new ATS/ERS pulmonary function test interpretation guidelines
Respiratory Medicine (2007) 101, 2336 2342 Impact of the new ATS/ERS pulmonary function test interpretation guidelines Mary Elizabeth Kreider a,, Michael A. Grippi a,b a Division of Pulmonary, Allergy,
More informationONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS
R2 (REVISED MANUSCRIPT BLUE 200208-877OC) ONLINE DATA SUPPLEMENT - ASTHMA INTERVENTION PROGRAM PREVENTS READMISSIONS IN HIGH HEALTHCARE UTILIZERS Mario Castro, M.D., M.P.H. Nina A. Zimmermann R.N. Sue
More information6- Lung Volumes and Pulmonary Function Tests
6- Lung Volumes and Pulmonary Function Tests s (PFTs) are noninvasive diagnostic tests that provide measurable feedback about the function of the lungs. By assessing lung volumes, capacities, rates of
More informationRESPIRATORY PHYSIOLOGY Pre-Lab Guide
RESPIRATORY PHYSIOLOGY Pre-Lab Guide NOTE: A very useful Study Guide! This Pre-lab guide takes you through the important concepts that where discussed in the lab videos. There will be some conceptual questions
More informationEffect of change of reference standard to NHANES III on interpretation of spirometric abnormality
ORIGINAL RESEARCH Effect of change of reference standard to NHANES III on interpretation of spirometric abnormality Akshay Sood Beth K Dawson Joseph Q Henkle Patricia Hopkins-Price Clifford Qualls Department
More informationCIRCULAR INSTRUCTION REGARDING ESTABLISHMENT OF IMPAIRMENT DUE TO OCCUPATIONAL LUNG DISEASE FOR THE PURPOSES OF AWARDING PERMANENT DISABLEMENT
Circular Instruction 195 CIRCULAR INSTRUCTION REGARDING ESTABLISHMENT OF IMPAIRMENT DUE TO OCCUPATIONAL LUNG DISEASE FOR THE PURPOSES OF AWARDING PERMANENT DISABLEMENT COMPENSATION FOR OCCUPATIONAL INJURIES
More informationQuality Assurance Mapping Your QC Program Equipment and Test Quality. Susan Blonshine RRT, RPFT, FAARC, AE-C
Quality Assurance Mapping Your QC Program Equipment and Test Quality Susan Blonshine RRT, RPFT, FAARC, AE-C How to Begin Gather resources Define PF scope of service Procedures performed Equipment Describe
More informationInterpreting pulmonary function tests: Recognize the pattern, and the diagnosis will follow
REVIEW FEYROUZ AL-ASHKAR, MD Department of General Internal Medicine, The Cleveland Clinic REENA MEHRA, MD Department of Pulmonary and Critical Care Medicine, University Hospitals, Cleveland PETER J. MAZZONE,
More informationThe Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults
The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults DAVID B. COULTAS, DOUGLAS MAPEL, ROBERT GAGNON, and EVA LYDICK The University of Florida Health Science
More informationSpirometry in primary care
Spirometry in primary care Wednesday 13 th July 2016 Dr Rukhsana Hussain What is spirometry? A method of assessing lung function Measures volume of air a patient can expel after a full inspiration Recorded
More informationSpirometry Training Courses. Spirometry for. Thoracic Society of Australia and New Zealand. June Developed in partnership with
Standards for Spirometry Training Courses Companion Document to Standards for the Delivery of Spirometry for Coal Mine Workers Thoracic Society of Australia and New Zealand June 2017 Developed in partnership
More informationSpirometry Quality-Control Strategies in a Multinational Study of the Prevalence of Chronic Obstructive Pulmonary Disease
Spirometry Quality-Control Strategies in a Multinational Study of the Prevalence of Chronic Obstructive Pulmonary Disease Rogelio Pérez-Padilla MD, Juan Carlos Vázquez-García MD, María Nelly Márquez MD,
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationComparison of Different Spirometry Reference Equations in Predicting Lung Function in Sri Lankan School Children
Original Article Comparison of Different Spirometry Reference Equations in Predicting Lung Function in Sri Lankan School Children G Liyanage 1 *, BDW Jayamanne 2, Aaqiff M 3 1 Department of Paediatrics
More informationM easurement of lung function is a well established part
1021 ORIGINAL ARTICLE Feasibility of measuring lung function in preschool children W Nystad, S O Samuelsen, P Nafstad, E Edvardsen, T Stensrud, J J K Jaakkola... See end of article for authors affiliations...
More informationSPIROMETRY. Performance and Interpretation for Healthcare Professionals. Faculty of Respiratory Physiology IICMS. Version 1 April 2015
SPIROMETRY Performance and Interpretation for Healthcare Professionals Faculty of Respiratory Physiology IICMS Version 1 April 2015 Authors: Maria Mc Neill & Geraldine Nolan www.iars.ie Contents Page Background
More informationPrevalence of undetected persistent airflow obstruction in male smokers years old
2 Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old Geijer RMM Sachs APE Hoes AW Salomé PL Lammers J-WJ Verheij TJM Published in: Family Practice 2005;22:485-489 Abstract
More informationChapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 3 Pulmonary Function Study Assessments 1 Introduction Pulmonary function studies are used to: Evaluate pulmonary causes of dyspnea Differentiate between obstructive and restrictive pulmonary disorders
More informationPhysiology lab (RS) First : Spirometry. ** Objectives :-
Physiology lab (RS) ** Objectives :- 1. Spirometry in general. 2. Spirogram (volumes and capacities). 3. The importance of vital capacity in diagnosis. 4. Flow volume loop. 5. Miss Arwa s part (the practical
More informationSupramaximal flow in asthmatic patients
Eur Respir J ; 19: 13 17 DOI: 1.113/93193..51 Printed in UK all rights reserved Copyright #ERS Journals Ltd European Respiratory Journal ISSN 93-193 Supramaximal flow in asthmatic patients H. Sala*, A.
More informationPULMONARY FUNCTION. VOLUMES AND CAPACITIES
PULMONARY FUNCTION. VOLUMES AND CAPACITIES The volume of air a person inhales (inspires) and exhales (expires) can be measured with a spirometer (spiro = breath, meter = to measure). A bell spirometer
More information2.0 Scope: This document is to be used by the DCS staff when collecting participants spirometry measurements using the TruFlow Easy-On Spirometer.
Title: Spirometry Version Date: 2014-AUG-20 Effective Date: 2014-OCT-15 Data Collection Site (DCS) Version: 2.2 Document Number: Number of Pages: SOP_DCS_0012 7 1.0 Purpose: The purpose of this document
More informationCOPD most commonly refers to chronic bronchitis, Mild and Moderate-to-Severe COPD in Nonsmokers* Distinct Demographic Profiles
Mild and Moderate-to-Severe COPD in Nonsmokers* Distinct Demographic Profiles Carolyn E. Behrendt, PhD Study objective: To investigate the risk of COPD among nonsmokers. Design: Case-control study, logistic
More informationForced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag study
Eur Respir J 2001; 18: 770 779 Printed in UK all rights reserved Copyright ERS Journals Ltd 2001 European Respiratory Journal ISSN 0903-1936 Forced spirometry reference values for Norwegian adults: the
More informationChronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort
Respiratory Medicine (2009) 103, 224e229 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a
More information/FVC ratio in children of 7-14 years of age from Western Rajasthan
Article FEV 1, FVC, FEV 1 /FVC ratio in children of 7-14 years of age from Western Rajasthan Meenakshi Sharma 1, Rambabu Sharma 2, Neelam Singh 3, Kusum Gaur 4 Abstract Background: The knowledge of pulmonary
More informationPrediction equations for pulmonary function values in healthy children in Mashhad city, North East Iran
ORIGINAL ARTICLE Prediction equations for pulmonary function values in healthy children in Mashhad city, North East Iran Syad Saleh Tabatabaie 1, Mohammad Hossein Boskabady 1,2, Sakinah Shah Mohammadi
More informationC hronic obstructive pulmonary disease (COPD) is one of
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Developing COPD: a 25 year follow up study of the general population A Løkke, P Lange, H Scharling, P Fabricius, J Vestbo... See end of article for authors affiliations...
More informationINTRODUCTION METHODS. Alanna M. Chamberlain, MPH; Matthew B. Schabath, PhD; Aaron R. Folsom, MD
ASSOCIATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ALL-CAUSE MORTALITY IN BLACKS AND WHITES: THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY Objective: To determine the burden of chronic obstructive
More informationIndian Journal of Basic & Applied Medical Research; September 2013: Issue-8, Vol.-2, P
Original article: Study of pulmonary function in different age groups Dr.Geeta J Jagia*,Dr.Lalita Chandan Department of Physiology, Seth GS Medical College, Mumbai, India *Author for correspondence: drgrhegde@gmail.com
More informationThis article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution
More informationOriginal Contributions
Original Contributions Reproducibility and Validity of a Handheld Spirometer R Graham Barr MD DrPH, Kimberly J Stemple MPH, Sonia Mesia-Vela PhD, Robert C Basner MD, Susan J Derk MA, Paul K Henneberger
More informationSpirometry: an essential clinical measurement
Shortness of breath THEME Spirometry: an essential clinical measurement BACKGROUND Respiratory disease is common and amenable to early detection and management in the primary care setting. Spirometric
More information3.0 METHODS. 3.1 Participants
3.0 METHODS 3.1 Participants There were initially twenty participants studied in this experiment. The age range was between 18-50 years of age. The nine workers came from a private landscape company with
More informationPatient assessment - spirometry
Patient assessment - spirometry STEP 1 Learning objectives This module will provide you with an understanding of spirometry and the role it plays in aiding the diagnosis of lung diseases, particularly
More informationPortable Spirometry During Acute Exacerbations of Asthma in Children
Journal of Asthma, 46:122 125, 2009 Copyright C 2009 Informa Healthcare USA, Inc. ISSN: 0277-0903 print / 1532-4303 online DOI: 10.1080/02770900802460522 ORIGINAL ARTICLE Portable Spirometry During Acute
More informationSpirometric Standards and Patient Characteristics: An Exploratory Study of Factors Affecting Fulfillment in Routine Clinical Practice
Spirometric Standards and Patient Characteristics: An Exploratory Study of Factors Affecting Fulfillment in Routine Clinical Practice Jordi Giner MSc RN, Vicente Plaza MD PhD, Jordi Rigau PhD, Judit Solà
More informationRespiratory Physiology In-Lab Guide
Respiratory Physiology In-Lab Guide Read Me Study Guide Check Your Knowledge, before the Practical: 1. Understand the relationship between volume and pressure. Understand the three respiratory pressures
More informationStandardisation of spirometry
Eur Respir J 2005; 26: 319 338 DOI: 10.1183/09031936.05.00034805 CopyrightßERS Journals Ltd 2005 SERIES ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING Edited by V. Brusasco, R. Crapo and
More informationFVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction
Original Research PSYCHOLOGICAL TESTING FVC to Slow Inspiratory Vital Capacity Ratio* A Potential Marker for Small Airways Obstruction Judith Cohen, MD; Dirkje S. Postma, MD, PhD; Karin Vink-Klooster;
More informationTHE SOUTH AFRICAN SOCIETY OF OCCUPATIONAL MEDICINE
THE SOUTH AFRICAN SOCIETY OF OCCUPATIONAL MEDICINE SPIROMETRY IN INDUSTRY SASOM GUIDELINE ISBN: ISBN: 978-1-919727-72-1 2011 by SASOM All rights are reserved. No part of this publication may be reproduced,
More informationDo current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?
Respiratory Medicine (2006) 100, 458 462 Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma? Haim S. Bibi a,, David Feigenbaum a, Mariana Hessen
More informationSilica dust and COPD, is there an association?
Silica dust and COPD, is there an association? K. Ulm Institute for Medical Statistics and Epidemiology University of Technology, Munich Germany 1 Outline: - what is COPD? - some fact about COPD - what
More informationRegression Equations for Spirometry in Children Aged 6 to 17 Years in Delhi Region
Short Communication Regression Equations for Spirometry in Children Aged 6 to 17 Years in Delhi Region S.K. Chhabra 1, V.K. Vijayan 2, M. Rahman 3, V. Mittal 1 and P.D. Singh 1 Departments of Cardio-respiratory
More informationO ccupational asthma (OA) is the most commonly
58 ORIGINAL ARTICLE Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures S M Tarlo, G M Liss, K S Yeung... See end of
More informationC hronic obstructive pulmonary disease (COPD) is an
388 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study D M Mannino, A S Buist,
More informationInt. J. Pharm. Sci. Rev. Res., 34(2), September October 2015; Article No. 24, Pages: Role of Spirometry in Diagnosis of Respiratory Diseases
Review Article Role of Spirometry in Diagnosis of Respiratory Diseases Dipti Mohapatra 1, Tapaswini Mishra 1, Manasi Behera 1, Nibedita Priyadarsini 1, Arati Mohanty 1, *Prakash Kumar Sasmal 2 1 Department
More informationPULMONARY FUNCTION TEST(PFT)
PULMONARY FUNCTION TEST(PFT) Objectives: By the end of the present lab, students should be able to: 1. Record lung volumes and capacities and compare them with those of a typical person of the same gender,
More informationValidation of Lung Age Measured by Spirometry and Handy Electronic FEV1/FEV6 Meter in Pulmonary Diseases
ORIGINAL ARTICLE Validation of Lung Age Measured by Spirometry and Handy Electronic FEV1/FEV6 Meter in Pulmonary Diseases Reiko Toda 1, Tomoaki Hoshino 1, Tomotaka Kawayama 1, Haruki Imaoka 1, Yuki Sakazaki
More information